Codes Combine Co., Ltd. (KOSDAQ:047770)
3,080.00
+80.00 (2.67%)
At close: Jan 26, 2026
Codes Combine Revenue
Codes Combine had revenue of 9.56B KRW in the quarter ending September 30, 2025, with 6.41% growth. This brings the company's revenue in the last twelve months to 38.71B, down -2.63% year-over-year. In the year 2024, Codes Combine had annual revenue of 39.60B, down -5.61%.
Revenue (ttm)
38.71B
Revenue Growth
-2.63%
P/S Ratio
2.91
Revenue / Employee
774.24M
Employees
50
Market Cap
112.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 39.60B | -2.36B | -5.61% |
| Dec 31, 2023 | 41.96B | 2.90B | 7.44% |
| Dec 31, 2022 | 39.05B | 789.22M | 2.06% |
| Dec 31, 2021 | 38.26B | 5.78B | 17.79% |
| Dec 31, 2020 | 32.49B | -3.33B | -9.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The Nature Holdings | 501.19B |
| SMCore.Inc | 175.30B |
| Pungguk Ethanol | 164.73B |
| Hyundai Ezwel | 137.12B |
| DK Life Science | 131.17B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 102.11B |
| FNS TECH. | 97.55B |
| Humasis | 35.60B |